| Coronavirus disease 2019 (COVID-19) and mental health for children and adolescents E Golberstein, H Wen, BF Miller JAMA pediatrics 174 (9), 819-820, 2020 | 1529 | 2020 |
| The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances H Wen, JM Hockenberry, JR Cummings Journal of Health Economics 42, 64-80, 2015 | 535* | 2015 |
| Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees H Wen, JM Hockenberry JAMA internal medicine 178 (5), 673-679, 2018 | 267 | 2018 |
| Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States JR Cummings, H Wen, M Ko, BG Druss JAMA psychiatry 71 (2), 190-196, 2014 | 228 | 2014 |
| Impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment H Wen, JM Hockenberry, TF Borders, BG Druss Medical Care 55 (4), 336-341, 2017 | 214 | 2017 |
| Improving access to mental health services for youth in the United States JR Cummings, H Wen, BG Druss JAMA 309 (6), 553-554, 2013 | 175 | 2013 |
| Lack of access to specialists associated with mortality and preventable hospitalizations of rural Medicare beneficiaries KJ Johnston, H Wen, KE Joynt Maddox Health Affairs 38 (12), 1993-2002, 2019 | 163 | 2019 |
| States with prescription drug monitoring mandates saw a reduction in opioids prescribed to Medicaid enrollees H Wen, BR Schackman, B Aden, Y Bao Health Affairs 36 (4), 733-741, 2017 | 148 | 2017 |
| The effect of Medicaid expansion on crime reduction: evidence from HIFA-waiver expansions H Wen, JM Hockenberry, JR Cummings Journal of Public Economics 154, 67-94, 2017 | 140* | 2017 |
| Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use H Wen, JM Hockenberry, PJ Jeng, Y Bao Health Affairs 38 (9), 1550-1556, 2019 | 119 | 2019 |
| The effect of medical marijuana laws on marijuana-related attitude and perception among US adolescents and young adults H Wen, JM Hockenberry, BG Druss Prevention Science 20 (2), 215–223, 2019 | 119 | 2019 |
| Geography and the Medicaid mental health care infrastructure: implications for health care reform JR Cummings, H Wen, M Ko, BG Druss JAMA psychiatry 70 (10), 1084-1090, 2013 | 110 | 2013 |
| Racial/ethnic differences in treatment for substance use disorders among US adolescents JR Cummings, H Wen, BG Druss Journal of the American Academy of Child & Adolescent Psychiatry 50 (12 …, 2011 | 104 | 2011 |
| Effect of Medicaid expansions on health insurance coverage and access to care among low‐income adults with behavioral health conditions H Wen, BG Druss, JR Cummings Health Services Research 50 (6), 1787-1809, 2015 | 96 | 2015 |
| State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation H Wen, JR Cummings, JM Hockenberry, LM Gaydos, BG Druss JAMA psychiatry 70 (12), 1355-1362, 2013 | 81 | 2013 |
| Trends In buprenorphine prescribing by physician specialty H Wen, TF Borders, JR Cummings Health Affairs 38 (1), 24-28, 2019 | 69 | 2019 |
| Association between patient cognitive and functional status and Medicare total annual cost of care: implications for value-based payment KJ Johnston, H Wen, JM Hockenberry, KE Joynt Maddox JAMA internal medicine 178 (11), 1489-1497, 2018 | 64 | 2018 |
| Medicaid acceptance by psychiatrists before and after Medicaid expansion H Wen, AS Wilk, BG Druss, JR Cummings JAMA psychiatry 76(9), 981-983, 2019 | 63 | 2019 |
| Medicaid expansion associated with reductions in preventable hospitalizations H Wen, KJ Johnston, L Allen, TM Waters Health Affairs 38 (11), 1845-1849, 2019 | 49 | 2019 |
| Association of buprenorphine-waivered physician supply with buprenorphine treatment use and prescription opioid use in Medicaid enrollees H Wen, JM Hockenberry, HA Pollack JAMA network open 1 (5), e182943-e182943, 2018 | 45 | 2018 |
Janet R. CummingsDept. of Health Policy and Management, Emory Universityemory.edu의 이메일 확인됨
